Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis.
Hongjoo J. Lee, Gwang Hun Jeong, H. Li, M S Kim, J S Kim, S J Park, Yi Han, Keum Hwa Lee, Andreas Kronbichler, Seok-Il Hong, Ramy Abou Ghayda, Claudio Luchini, Alessia Nottegar, A Koyanagi, Lee Smith, Linu Abraham Jacob, Elena Dragioti, Joaquim Raduà, Sarah Cargnin, Salvatore Terrazzino, Terry Thompson, Dong Keon Yon, S W Lee, J M Yang, Paul Wasuwanich, Jae Il Shin, Gabriele Gamerith (2021). Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis.. , 25(20), DOI: https://doi.org/10.26355/eurrev_202110_26993.
